Whodda ever thunk that?? Holy heck! Better buy some...
All this urgency over some pre-clinical murine models...???
Hang on tight, cuz the big-butted short teddies are gonna play this one hard on Tuesdays Abi combo news.
When the dust clears....be sure you've still got a hand to play...cuz they want your cheap shares.
Nomad evaporated after declaring & encouraging a short at $4.36...
When it failed...My take is - so did his mission...hence his disappearance.
Gisela bought a healthy fix a few months ago at $4.39...
I started buying again at $4.45...and have added on every down day since.
The AACR data should give us some short-term stability.
I suspect we'll hit the throttle with MTC OS data - due date anybody's guess...